se of topical phenytoin and loperamide for the treatment of neuropathic pai

Phase 2

• Conditions: Treatment of peripheral neuropathic pain; Nervous System Diseases

• Registration Number: ISRCTN18843536
• Lead Sponsor: niversity Clinical Centre Maribor

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-03-12
• Last Update Posted: 25 March 2024
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Patients experiencing peripheral neuropathic pain and currently under treatment at the Pain Management Clinic of the Department of Anesthesiology, Intensive Therapy, and Pain Management at the University Medical Centre Maribor
2. Adults identified with neuropathic pain using the DN-4 questionnaire, scoring at least 4 points out of 10

Exclusion Criteria

1. Allergy to phenytoin or loperamide
2. Presence of central neuropathy (multiple sclerosis, spinal cord injury, neuropathy following a stroke)
3. Pregnancy or the possibility of pregnancy
4. Treatment of neuropathic pain with any topical preparation in the last 30 days

Study & Design

• Study Type: Interventional
• Study Design: Not specified